Lumida
/AZN
⌘K
AstraZeneca PLC

AstraZeneca PLC

AZN
$160.17USD↑+0.33%+0.53 today

MARKET CAP

134.8B

P/E (TTM)

69.6x

FWD P/E

—

DAY RANGE

$158 – $162

52W RANGE

$146
$213

AI Summary

Stalk
Sell NowMedium

AZN remains in a Stage 3 downtrend with lower highs and lows under declining EMAs. Supply dominates, and recent rallies are being rejected at resistance. We favor initiating bearish engagements now, selling into the pullback at dynamic EMA resistance.

  • ↑Q2 revenue +6% to $12.5B on strong innovative drug demand.
  • ↑YTD 31 regulatory approvals bolster pipeline momentum.
  • ↓Impending exclusivity losses on key products like Farciga and Brilinta.
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income